Al-Mohanna M - Search Results

1

Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.

Alaiya AA, Al-Mohanna M, Aslam M, Shinwari Z, Al-Mansouri L, Al-Rodayan M, Al-Eid M, Ahmad I, Hanash K, Tulbah A, Bin Mahfooz A, Adra C. Alaiya AA, et al. Among authors: al mohanna m. Int J Oncol. 2011 Apr;38(4):1047-57. doi: 10.3892/ijo.2011.937. Epub 2011 Feb 8. Int J Oncol. 2011. PMID: 21305254

2

Clinical cancer proteomics: promises and pitfalls.

Alaiya A, Al-Mohanna M, Linder S. Alaiya A, et al. Among authors: al mohanna m. J Proteome Res. 2005 Jul-Aug;4(4):1213-22. doi: 10.1021/pr050149f. J Proteome Res. 2005. PMID: 16083271 Review.

3

Development of a novel poly bisphosphonate conjugate for treatment of skeletal metastasis and osteoporosis.

Holmberg AR, Lerner UH, Alayia AA, Al-Mohanna M, Adra C, Marquez M, Meurling L, Nilsson S. Holmberg AR, et al. Among authors: al mohanna m. Int J Oncol. 2010 Sep;37(3):563-7. doi: 10.3892/ijo_00000705. Int J Oncol. 2010. PMID: 20664925

4

The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum.

Alsemari A, Alkhodairy F, Aldakan A, Al-Mohanna M, Bahoush E, Shinwari Z, Alaiya A. Alsemari A, et al. Among authors: al mohanna m. BMC Complement Altern Med. 2014 Mar 29;14:114. doi: 10.1186/1472-6882-14-114. BMC Complement Altern Med. 2014. PMID: 24679057 Free PMC article.

5

TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.

Qasem E, Murugan AK, Al-Hindi H, Xing M, Almohanna M, Alswailem M, Alzahrani AS. Qasem E, et al. Endocr Relat Cancer. 2015 Dec;22(6):901-8. doi: 10.1530/ERC-15-0396. Epub 2015 Sep 9. Endocr Relat Cancer. 2015. PMID: 26354077

6

Divergent gender identity in three siblings with 46XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation.

Bin-Abbas B, Al-Humaida D, Al-Sagheir A, Qasem E, Almohanna M, Alzahrani AS. Bin-Abbas B, et al. Endocr Pract. 2014 Oct;20(10):e191-7. doi: 10.4158/EP14179.CR. Endocr Pract. 2014. PMID: 25100385

7

p53 is dispensable for UV-induced cell cycle arrest at late G(1) in mammalian cells.

Al-Mohanna MA, Al-Khodairy FM, Krezolek Z, Bertilsson PA, Al-Houssein KA, Aboussekhra A. Al-Mohanna MA, et al. Carcinogenesis. 2001 Apr;22(4):573-8. doi: 10.1093/carcin/22.4.573. Carcinogenesis. 2001. PMID: 11285191

8

The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light.

Al-Mohanna MA, Al-Khalaf HH, Al-Yousef N, Aboussekhra A. Al-Mohanna MA, et al. Nucleic Acids Res. 2007;35(1):223-33. doi: 10.1093/nar/gkl1075. Epub 2006 Dec 7. Nucleic Acids Res. 2007. PMID: 17158160 Free PMC article.

9

Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.

Alzahrani AS, Qasem E, Murugan AK, Al-Hindi HN, AlKhafaji D, Almohanna M, Xing M, Alhomaidah D, AlSwailem M. Alzahrani AS, et al. Thyroid. 2016 Feb;26(2):235-41. doi: 10.1089/thy.2015.0510. Epub 2016 Jan 21. Thyroid. 2016. PMID: 26711586

10

The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin.

Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, A Al-Hussein K, Aboussekhra A. Al-Mohanna MA, et al. Oncogene. 2004 Jan 8;23(1):201-12. doi: 10.1038/sj.onc.1206927. Oncogene. 2004. PMID: 14712225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters